Sandercock Brett bought RMD
May 8, 2024 · Form 4 insider transaction
Sandercock Brett bought 12,000 shares of ResMed Inc. at $101.64 per share, a transaction worth $1.22M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,000
Price
$101.64
Total value
$1.22M
InsiderSandercock Brett
Role—
CompanyResMed Inc. (RMD)
SecurityResMed Common Stock
Transaction codeM: Option exercise
Transaction dateMay 8, 2024
Filing dateMay 10, 2024
Shares owned after105,056
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction was conducted under a Rule 10b5-1 plan adopted February 8, 2024.; Includes 94.177 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan.